Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

856
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
856
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

137
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
137
Bone Remodeling01:40

Bone Remodeling

40.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

11β-Hydroxysteroid dehydrogenase type 1 deficiency causes sexual dimorphism in body composition and bone mass in response to caloric restriction.

JBMR plus·2026
Same author

Neuroendocrine and neural control of bone mass in health and disease.

The Journal of clinical investigation·2026
Same author

Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis.

Frontiers in endocrinology·2026
Same author

Glycerol-driven TNAP activation in thermogenesis and mineralization.

Nature·2026
Same author

GLP-1 Receptor Agonists.

The New England journal of medicine·2026
Same author

Expansion of bone marrow adipocytes in obese mice leads to PD-L1-driven bone marrow immunosuppression and osteoclastogenesis.

Bone research·2026

Related Experiment Video

Updated: Dec 23, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

86.9K

Parkinson's disease and osteoporosis: basic and clinical implications.

Carolina A Figueroa1, Clifford J Rosen1

  • 1Maine Medical Center Research Institute, Scarborough, ME, USA.

Expert Review of Endocrinology & Metabolism
|April 28, 2020
PubMed
Summary

Parkinson's disease (PD) impacts bone health, increasing osteoporosis risk. Further research is needed to understand neuro/endocrine links and optimize fracture prevention strategies for PD patients.

Keywords:
Parkinson’s Diseasebone mineral densityfallsosteoporosis

More Related Videos

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.5K

Related Experiment Videos

Last Updated: Dec 23, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

86.9K
Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.5K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by alpha-synuclein accumulation and motor dysfunction.
  • PD patients face increased hospitalizations, prolonged recovery, and higher mortality, with secondary osteoporosis being a frequent, underrecognized complication.
  • Osteoporosis in PD is linked to a poorer prognosis, necessitating a deeper understanding of its underlying mechanisms.

Purpose of the Study:

  • To review the systemic pathophysiology of Parkinson's disease concerning bone health.
  • To explore neuro/endocrine pathways linking PD to skeletal complications.
  • To identify therapeutic strategies and evidence gaps for osteoporotic fractures in PD.

Main Methods:

  • Systematic literature search on PubMed for articles published in the last 20 years.
  • Focus on clinical features of PD and bone health status.
  • Review of neuro/endocrine mechanisms, therapies, and research gaps.

Main Results:

  • PD pathophysiology has systemic implications affecting bone health.
  • Neuro/endocrine factors likely mediate the impact of PD on the skeleton.
  • Current understanding of skeletal comorbidities and fracture therapies in PD is incomplete.

Conclusions:

  • Understanding the systemic effects of PD on bone remodeling is crucial.
  • Investigating the role of dopaminergic signaling and alpha-synuclein in bone health is essential.
  • A systematic approach is needed to guide the use of osteoporosis treatments for fracture prevention in PD.